Sox2 promotes tamoxifen resistance in breast cancer cells

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch

Erschienen in
Sox2 promotes tamoxifen resistance in breast cancer cells ; volume:6 ; number:1 ; year:2014 ; pages:66-79 ; extent:14
EMBO molecular medicine / European Molecular Biology Organization ; 6, Heft 1 (2014), 66-79 (gesamt 14)

Urheber
Piva, Marco
Domenici, Giacomo
Iriondo, Oihana
Rábano, Miriam
Simões, Bruno M.
Comaills, Valentine
Barredo, Inmaculada
López‐Ruiz, Jose A.
Zabalza, Ignacio
Kypta, Robert
Vivanco, Maria d. M.

DOI
10.1002/emmm.201303411
URN
urn:nbn:de:101:1-2023011307302602031137
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:31 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Piva, Marco
  • Domenici, Giacomo
  • Iriondo, Oihana
  • Rábano, Miriam
  • Simões, Bruno M.
  • Comaills, Valentine
  • Barredo, Inmaculada
  • López‐Ruiz, Jose A.
  • Zabalza, Ignacio
  • Kypta, Robert
  • Vivanco, Maria d. M.

Ähnliche Objekte (12)

Polyoxometalate inhibition of SOX2-mediated tamoxifen resistance in breast cancer

Polyoxometalate inhibition of SOX2-mediated tamoxifen resistance in breast cancer

The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy

The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy

USP36 promotes tumorigenesis and tamoxifen resistance in breast cancer by deubiquitinating and stabilizing ERα

USP36 promotes tumorigenesis and tamoxifen resistance in breast cancer by deubiquitinating and stabilizing ERα

AFF3 upregulation mediates tamoxifen resistance in breast cancers

AFF3 upregulation mediates tamoxifen resistance in breast cancers

Overexpression of COL11A1 confers tamoxifen resistance in breast cancer

Overexpression of COL11A1 confers tamoxifen resistance in breast cancer

Metabolic/hypoxial axis predicts tamoxifen resistance in breast cancer

Metabolic/hypoxial axis predicts tamoxifen resistance in breast cancer

LncRNA ATXN8OS enhances tamoxifen resistance in breast cancer

LncRNA ATXN8OS enhances tamoxifen resistance in breast cancer

Association of tamoxifen resistance and lipid reprogramming in breast cancer

Association of tamoxifen resistance and lipid reprogramming in breast cancer

Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer

Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer

Epigenetic silencing of SALL 2 confers tamoxifen resistance in breast cancer

Epigenetic silencing of SALL 2 confers tamoxifen resistance in breast cancer

Progesterone Receptor Membrane Component 1 Promotes Cell Proliferation and Tamoxifen Resistance through Alteration of Sexual Receptors in Breast Cancer

Progesterone Receptor Membrane Component 1 Promotes Cell Proliferation and Tamoxifen Resistance through Alteration of Sexual Receptors in Breast Cancer

Overcoming CYP2D6-mediated tamoxifen resistance in postmenopausal breast cancer : a PBPK approach

Hochschulschrift

Overcoming CYP2D6-mediated tamoxifen resistance in postmenopausal breast cancer : a PBPK approach

Verbundene Objekte